WHO ICTRP trial

Efficacy of Viable Cartilage Allograft in talar osteochondral lesions

ACTRN12624000412538 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting

Key facts

Trial ID ACTRN12624000412538
Public title Efficacy of Viable Cartilage Allograft in talar osteochondral lesions
Scientific title Efficacy of Viable Cartilage Allograft in talar osteochondral lesions
Primary sponsor Sydney Orthopaedic Foot and Ankle Research Institute
Secondary sponsors CONMED Corporation
Registry Australian New Zealand Clinical Trials Registry (ANZCTR)
Recruitment status Not Recruiting
Study type Interventional
Phase Not Applicable
Countries Australia
Conditions Osteochondral Lesion in the Talus; Osteochondral Lesion in the Talus;Musculoskeletal - Other muscular and skeletal disorders;Injuries and Accidents - Other injuries and accidents
Interventions Osteochondral lesion of the talus are common and can be present in upto 6.5% of the population. While some may be asymptomatic, others can cause pain affecting lifestyle and potential lead to accelerated wear and potential arthritis…
Registration date Apr 4, 2024
Target size 10
Secondary IDs Nil
Registry page anzctr.org.au

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations